Catálogo de publicaciones - libros
Título de Acceso Abierto
Venom and Toxin as Targeted Therapy
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
cane toad; n/a; B cell non-Hodgkin lymphoma; Malaysian cobras; complement system; decay accelerating factor; neuroblastoma; atopic dermatitis; complement dependent cytotoxicity; antioxidant enzymes; bacterial adhesion; cancer therapy; N. kaouthia; anuran skin secretion; frog; Apis mellifera syriaca; solid phase extraction; bee venom phospholipase A2 (bvPLA2); disintegrin; toad toxins; immunotoxins; ribosome-inactivating proteins; antimicrobial peptide (AMP); drug design; Moxetumomab pasudotox; snake venom; antiviral activity; in vitro effects; bombesin-related peptide; oxidative stress biomarkers; half-life; blood vessel formation; target therapy; 2; MYCN; indolealkylamines; Huachansu; membrane attack complex; bouganin; bee venom; SEM; anticancer activity; antimicrobial peptide; house dust mite extract (DFE); mannose receptor; O. hannah; bicarinalin; gastric cells; melittin; LC-ESI-MS; dermaseptin; smooth muscle; apoptosis; anticancer; N. sumatrana; Helicobacter pylori; inflammation; immunotherapy; atopic dermatitis (AD); immunotoxin; mantle cell lymphoma; clearance; mass spectrometry; Bougainvillea; rRNA N-glycosylase activity; fungal toxin; skin inflammation; targeted therapy; 4-dinitrochlorobenzene (DNCB); Bee venom; VEGF; Chansu; bufadienolides; obsessive–compulsive disorder (OCD); BLF1; antimicrobial activity; orellanine; VB6-845; acute lymphoblastic leukemia; ribosome-inactivating protein; CD206; molecular cloning; cancer; CD22; eIF4A
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-03921-190-6
País de edición
Suiza